CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Neutral
AI Analysis

Summary

Syndax Pharmaceuticals granted inducement stock option awards to nine new employees covering up to 213,300 shares under its 2023 Inducement Plan, with standard four-year vesting terms.

Importance:2/10
Sentiment:
0.00
employee equityinducement grantsstock optionsNASDAQ compliance
Related Companies

Read the original article

Published by GlobeNewswire Pharma on October 2, 2026 8:01 PM

Read Original